Summary
Precision Biologics, Inc. (PBI) is a clinical stage biotechnology company that offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. The company’s services include development of pharmaceutical and diagnostic products for the early detection and treatment of cancer and developing innovative diagnostics and therapeutics that target tumors with precision. PBI also provides therapeutic drug candidate for pancreatic and colorectal cancers, therapeutic drug, tumor specific antigen, pre clinical tests, experimental therapy, and other diagnostic programs. Its services include discovery, development and commercialization of novel cancer therapeutics and diagnostics. The company has operations in Dallas, Rockville, and New York. PBI is headquartered in Dallas, Texas, the US.
Precision Biologics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Precision Biologics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Precision Biologics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Precision Biologics Raises USD0.79 Million in Venture Financing 11
Precision Biologics Raises USD10.5 Million in Venture Financing 12
Precision Biologics Raises US$3.3 Million In Venture Financing 13
Precision Biologics Raises USD5.3 Million in Venture Financing 14
Partnerships 15
Precision Biologics Enters into R&D Agreement with National Cancer Institute 15
Merck Enters into Development Agreement with Precision Biologics 16
Licensing Agreements 17
Selexis Enters Into Licensing Agreement With Neogenix Oncology 17
Acquisition 18
NantWorks Acquires Majority Stake in Precision Biologics for USD50 Million 18
Precision Biologics Completes Acquisition Of Neogenix Oncology 19
Precision Biologics, Inc. - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Precision Biologics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Precision Biologics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Precision Biologics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Precision Biologics Raises USD0.79 Million in Venture Financing 11
Precision Biologics Raises USD10.5 Million in Venture Financing 12
Precision Biologics Raises US$3.3 Million In Venture Financing 13
Precision Biologics Raises USD5.3 Million in Venture Financing 14
Precision Biologics Enters into R&D Agreement with National Cancer Institute 15
Merck Enters into Development Agreement with Precision Biologics 16
Selexis Enters Into Licensing Agreement With Neogenix Oncology 17
NantWorks Acquires Majority Stake in Precision Biologics for USD50 Million 18
Precision Biologics Completes Acquisition Of Neogenix Oncology 19
Precision Biologics, Inc., Key Competitors 20
Precision Biologics, Inc., Key Employees 21
Precision Biologics, Inc., Other Locations 22
Precision Biologics, Inc., Subsidiaries 22
List of Figures
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Precision Biologics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Precision Biologics, Inc., Medical Devices Deals, 2010 to YTD 2016 9